Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Psychotropics

K G Goldaber1

  • 1Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center al Dallas 75235-9032, USA.

Seminars in Perinatology
|April 1, 1997
PubMed
Summary
This summary is machine-generated.

This review examines the risks of commonly prescribed psychotropic medications during pregnancy, focusing on their association with congenital malformations. It synthesizes findings from various study types to inform clinical practice.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Outcomes among term infants when two-hour postnatal pH is compared with pH at delivery.

American journal of obstetrics and gynecology·2001
Same author

Subcutaneous tissue: to suture or not to suture at cesarean section.

Infectious diseases in obstetrics and gynecology·1994
Same author

Correlations between obstetric clinical events and umbilical cord blood acid-base and blood gas values.

Clinical obstetrics and gynecology·1993
Same author

Postpartum perineal morbidity after fourth-degree perineal repair.

American journal of obstetrics and gynecology·1993
Same author

Pathologic fetal acidemia.

Obstetrics and gynecology·1991

Area of Science:

  • Perinatal medicine
  • Psychopharmacology
  • Teratology

Background:

  • Psychotropic medications are frequently prescribed to pregnant individuals.
  • Understanding the risks associated with these agents is crucial for maternal and fetal well-being.
  • Congenital malformations represent a significant concern in pregnancies exposed to medication.

Purpose of the Study:

  • To summarize the risks of commonly prescribed psychopharmacological agents during pregnancy.
  • To describe the association between antidepressants, antianxiety agents, and antipsychotic agents and congenital malformations.
  • To provide an evidence-based overview for clinicians managing pregnant patients on psychotropic medication.

Main Methods:

  • Review of epidemiological studies.

Related Experiment Videos

  • Analysis of cohort studies.
  • Inclusion of case reports and animal studies to assess medication risks.

    • Main Results:

    • The article synthesizes data on the teratogenic potential of various psychotropic drug classes.
    • Specific associations between certain antidepressants, antianxiety agents, and antipsychotics and congenital malformations are discussed.
    • Evidence from human and animal studies is evaluated to understand risk profiles.

    Conclusions:

    • The use of psychopharmacological agents during pregnancy requires careful risk-benefit assessment.
    • Further research is needed to fully elucidate the teratogenic effects of specific psychotropic medications.
    • Informed decision-making is essential for optimizing outcomes in pregnant individuals requiring psychotropic treatment.